Susquehanna International Group, LLP Ambrx Biopharma Inc. Transaction History

Susquehanna International Group, LLP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$7.66 - $16.46 $230,994 - $496,367	-30,156 Reduced 37.03%	51,290 $844,000
Q1 2023 May 16, 2023	BUY	$1.46 - $12.54 $64,130 - $550,819	43,925 Added 117.07%	81,446 $726,000
Q4 2022 Feb 14, 2023	BUY	$0.41 - $4.54 $7,503 - $83,086	18,301 Added 95.22%	37,521 $85,000
Q3 2022 Nov 14, 2022	BUY	$1.06 - $2.96 $20,373 - $56,891	19,220 New	19,220 $21,000

31.2K

Ticker AMAM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,618,400
Market Cap $1.08B
Description
Ambrx Biopharma Inc., a clinical-stage biologics company, discovers and develops engineered precision biologics using its proprietary expanded genetic code technology platform. Its lead product candidate is ARX788, an anti-HER2 antibody-drug conjugate (ADC), which is investigated in various clinical trials for the treatment of breast cancer, gas...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.